Viewing StudyNCT06374459



Ignite Creation Date: 2024-05-06 @ 8:24 PM
Last Modification Date: 2024-10-26 @ 3:27 PM
Study NCT ID: NCT06374459
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-04-18
First Post: 2024-04-10

Brief Title: Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Sponsor: Washington University School of Medicine
Organization: Washington University School of Medicine

Conditions & Keywords Data

Conditions:
Name
Hormone Receptor Positive HER-2 Negative Metastatic Breast Cancer
Keywords:
Name View
Capecitabine View
Zunsemetinib View
ATI-450 View
MK-2 View
Bone metastasis View
Breast Cancer View
HR-positiveHER2-negative View